MSTR Strategy Price Prediction: Lower Prices INCOMING
1 extracted signal · 0 resolved · 1 still active
C-Zar Gets Crypto Independent analyst profile- Source published
- 28 Sept 2026, 23:43 UTC
- Recorded by Tahlil Plus
- 29 Sept 2026, 00:45 UTC
AI-generated source summary
The analysis focuses on MSTR, suggesting a bullish outlook based on technical indicators and price action. The broader trend on the daily chart indicates a potential continuation of the upward movement. Fibonacci retracement levels are identified, with key support around $121 and resistance levels noted near $160 and above $200. The analysis also mentions the potential for MSTR to reach $263. Oscillators like the RSI and MACD are discussed, with signals suggesting a shift from bearish to bullish momentum. The 1-hour chart shows a potential bullish divergence on the MACD, indicating a possible upward move. Support levels are identified around $126 and $115, with a key support at $81. The strategy suggests that if MSTR can hold support around $121, it may target higher levels, potentially breaking out of a downtrend. The failure bound for this bullish scenario is set below $121, invalidating the immediate upward trajectory.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
C-Zar Gets Crypto
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.